U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Advisory Committees
  3. Committees and Meeting Materials
  4. Human Drug Advisory Committees
  5. Endocrinologic and Metabolic Drugs Advisory Committee
  6. Endocrinologic and Metabolic Drugs Advisory Committee Roster
  1. Endocrinologic and Metabolic Drugs Advisory Committee

Endocrinologic and Metabolic Drugs Advisory Committee Roster

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

Current Number of Vacancies = 3

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chairperson
Cecilia C. Low Wang, MD
Expertise:  Endocrinology, Diabetes and Metabolism
Term: 07/01/2021 – 06/30/2025
Professor of Medicine, University of Colorado Anschutz Medical Campus
Clinician-Scientist, CPC Clinical Research
Director, Glucose Management Team, University of Colorado Hospital
MS8016, RC-1 South 7103
Aurora, Colorado 80045

Designated Federal Officer
LaToya Bonner, PharmD
Division of Advisory Committee and Consultant Management
Office of Executive Programs
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, Maryland 20993-0002
Phone: (301) 796-9001
Fax: (301) 847-8540
E-mail: EMDAC@fda.hhs.gov

Matthew T. Drake, MD, PhD
Expertise: Endocrinology, Diabetes, Metabolism, Nutrition
Term: 07/01/2022 – 6/30/2026
Associate Professor of Medicine
Chair, Metabolic Bone Disease Core Group
Division of Endocrinology
Mayo Clinic College of Medicine
200 First Street SW
Rochester, Minnesota 55905

Robert Alan Greevy, Jr., PhD
Expertise: Biostatistics, Pharmacoepidemiology
Term: 07/01/2022 – 06/30/2026
Associate Professor, Department of Biostatistics
Director, Health Services Research Biostatistics
Vanderbilt University Medical Center
2525 West End Avenue
Biostatistics, Suite/Room 11121A
Nashville, Tennessee 37203

** Ilan Irony, MD
Expertise: Endocrinology and Metabolism
Term: 7/8/2024 – 10/31/2027
Senior Director, Global Regulatory Lead
Janssen Research and Development
Johnson and Johnson Family of Companies
920 Route 202 South
Raritan, New Jersey 0886

Thomas Wang, MD
Expertise: Cardiology
Term: 07/01/2022 – 06/30/2026
Professor and Chair of Medicine
UT Southwestern Medical Center
Donald W. Seldin Distinguished Chair in Internal Medicine
5323 Harry Hines Blvd
Dallas, Texas 75390

* Consumer Representative (vacant)
** Industry Representative (non-voting)

Back to Top